Download original image
Fig. 3.
Survival analysis about the use of neoadjuvant chemotherapy (NACT): Overall survival (OS) (A, B) and disease-free survival (DFS) (C, D).
Ann Hepatobiliary Pancreat Surg 2023;27:180-8
https://doi.org/10.14701/ahbps.22-111
© 2023 Ann Hepatobiliary Pancreat Surg